Los Angeles Capital Management LLC Tg Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 123,401 shares of TGTX stock, worth $3.86 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
123,401
Previous 92,277
33.73%
Holding current value
$3.86 Million
Previous $1.64 Million
75.87%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding TGTX
# of Institutions
341Shares Held
87.6MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$481 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$356 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$284 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$112 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$100 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.54B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...